Synthesis and biological evaluation of 4-alkoxy-6,9-dichloro[1,2,4]triazolo[4,3-a]quinoxalines as inhibitors of TNF-α and IL-6
Authors:
- Antonio GuiradoAGAntonio Guirado
- José I. López SánchezJosé I. López Sánchez
- Antonio J. Ruiz-AlcarazARAntonio J. Ruiz-Alcaraz
- Delia BautistaDBDelia Bautista
- Jesús GálvezJGJesús Gálvez
- 1 August 2012
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 54, 87-94
Abstract
No abstract availableKeywords
Funding Information
- Fundación Séneca of the Comunidad Autónoma de la Región de Murcia (08755/PI/08)
This publication has 38 references indexed in Scilit:
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive reviewPharmacology & Therapeutics, 2008
- Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritisClinical Therapeutics, 2004
- Therapeutic strategies for rheumatoid arthritisNature Reviews Drug Discovery, 2003
- Tumor Necrosis Factor-α, Interleukin-6, and Nitric Oxide in Sterile Ascitic Fluid and Serum from Patients with Cirrhosis Who Subsequently Develop Ascitic Fluid InfectionDigestive Diseases and Sciences, 2001
- The Role of Chemokines and Chemokine Receptors in Mucosal InflammationInflammatory Bowel Diseases, 2000
- The Role of TNFα and IL-1 in Rheumatoid Arthritis2000
- Therapeutic Potential and Strategies for Inhibiting Tumor Necrosis Factor-αJournal of Medicinal Chemistry, 1999
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995
- Tumor necrosis factor-alpha in human arterial wall with atherosclerosisAtherosclerosis, 1991
- Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.Journal of Clinical Investigation, 1991